Zobrazeno 1 - 10
of 830
pro vyhledávání: '"Beumer W"'
Autor:
Michelle L; Department of Otolaryngology, Head and Neck Surgery, University of California Irvine, Orange, California, USA.; Beckman Laser Institute, University of California, Irvine, Irvine, California, USA., Torabi SJ; Department of Otolaryngology, Head and Neck Surgery, University of California Irvine, Orange, California, USA., Hutchison DM; Beckman Laser Institute, University of California, Irvine, Irvine, California, USA., Beumer W; Department of Otolaryngology, Head and Neck Surgery, University of California Irvine, Orange, California, USA., Wong BJ; Department of Otolaryngology, Head and Neck Surgery, University of California Irvine, Orange, California, USA.; Beckman Laser Institute, University of California, Irvine, Irvine, California, USA.; Department of Biomedical Engineering, Samueli School of Engineering, University of California Irvine, Irvine, California, USA.
Publikováno v:
Facial plastic surgery & aesthetic medicine [Facial Plast Surg Aesthet Med] 2023 Jul-Aug; Vol. 25 (4), pp. 353-354. Date of Electronic Publication: 2022 Sep 06.
Autor:
Kaltak M; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands.; Department of Human Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, the Netherlands.; Academic Alliance Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, and Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands., de Bruijn P; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Piccolo D; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK., Lee SE; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK., Dulla K; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Hoogenboezem T; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Beumer W; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Webster AR; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK.; Moorfields Eye Hospital, 162 City Road, EC1V 2PD London, UK., Collin RWJ; Department of Human Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, the Netherlands.; Academic Alliance Genetics, Radboud University Medical Center, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, and Maastricht University Medical Center+, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands., Cheetham ME; UCL, Institute of Ophthalmology, 11-43 Bath Street, EC1V 9EL London, UK., Platenburg G; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Swildens J; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Feb 18; Vol. 31, pp. 674-688. Date of Electronic Publication: 2023 Feb 18 (Print Publication: 2023).
Autor:
Hutchison DM; Beckman Laser Institute, University of California Irvine, Irvine, California, USA.; Department of Dermatology and Head and Neck Surgery, University of California Irvine, Irvine, California, USA., Hernandez K; Beckman Laser Institute, University of California Irvine, Irvine, California, USA., Park A; Beckman Laser Institute, University of California Irvine, Irvine, California, USA., Hakimi AA; Beckman Laser Institute, University of California Irvine, Irvine, California, USA., Mesinkovska NA; Beckman Laser Institute, University of California Irvine, Irvine, California, USA.; Department of Dermatology and Head and Neck Surgery, University of California Irvine, Irvine, California, USA., Kuan EC; Department of Otolaryngology, Head and Neck Surgery, University of California Irvine, Irvine, California, USA., Beumer W; Department of Otolaryngology, Head and Neck Surgery, University of California Irvine, Irvine, California, USA., Wong BJF; Beckman Laser Institute, University of California Irvine, Irvine, California, USA.; Department of Otolaryngology, Head and Neck Surgery, University of California Irvine, Irvine, California, USA.; Department of Biomedical Engineering, Samueli School of Engineering, University of California Irvine, Irvine, California, USA.
Publikováno v:
Facial plastic surgery & aesthetic medicine [Facial Plast Surg Aesthet Med] 2022 Nov-Dec; Vol. 24 (6), pp. 445-446. Date of Electronic Publication: 2021 Sep 14.
Autor:
N. Henig, Brinks, de Jager M, K. Lipinska, Brian Button, B. Matthee, Beumer W, Alessandra Livraghi-Butrico
Publikováno v:
J Aerosol Med Pulm Drug Deliv
Background: Eluforsen (previously known as QR-010) is a 33-mer antisense oligonucleotide under development for oral inhalation in cystic fibrosis (CF) patients with the delta F508 mutation. Previous work has shown that eluforsen restores CF transmemb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b78d024db553b59239dddd03416f4e
https://pubmed.ncbi.nlm.nih.gov/31120356
https://pubmed.ncbi.nlm.nih.gov/31120356
Autor:
Kim H; Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea., Lenoir S; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France., Helfricht A; ProQR Therapeutics NV, Leiden, Netherlands., Jung T; Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.; Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Huddinge, Sweden., Karneva ZK; ProQR Therapeutics NV, Leiden, Netherlands., Lee Y; Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea., Beumer W; ProQR Therapeutics NV, Leiden, Netherlands., van der Horst GB; ProQR Therapeutics NV, Leiden, Netherlands., Anthonijsz H; ProQR Therapeutics NV, Leiden, Netherlands., Buil LC; ProQR Therapeutics NV, Leiden, Netherlands., van der Ham F; ProQR Therapeutics NV, Leiden, Netherlands., Platenburg GJ; ProQR Therapeutics NV, Leiden, Netherlands., Purhonen P; Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Huddinge, Sweden., Hebert H; Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Huddinge, Sweden., Humbert S; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France., Saudou F; University Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, Grenoble, France., Klein P; ProQR Therapeutics NV, Leiden, Netherlands., Song JJ; Department of Biological Sciences, KI for the BioCentury, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
Publikováno v:
JCI insight [JCI Insight] 2022 Sep 08; Vol. 7 (17). Date of Electronic Publication: 2022 Sep 08.
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations.
Autor:
Dulla K; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Slijkerman R; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., van Diepen HC; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Albert S; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Dona M; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Beumer W; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Turunen JJ; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Chan HL; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Schulkens IA; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Vorthoren L; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., den Besten C; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Buil L; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Schmidt I; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Miao J; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Venselaar H; Center for Molecular and Biomolecular Informatics, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Zang J; University of Zürich, Institute of Molecular Life Sciences, 8057 Zürich, Switzerland., Neuhauss SCF; University of Zürich, Institute of Molecular Life Sciences, 8057 Zürich, Switzerland., Peters T; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Broekman S; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Pennings R; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Kremer H; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., Platenburg G; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands., Adamson P; ProQR Therapeutics, Zernikedreef 9, 2333 CK Leiden, the Netherlands; UCL, Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK., de Vrieze E; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands., van Wijk E; Department of Otorhinolaryngology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands. Electronic address: erwin.vanwyk@radboudumc.nl.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Aug 04; Vol. 29 (8), pp. 2441-2455. Date of Electronic Publication: 2021 Apr 23.
Autor:
Leenaars CH; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.; Faculty of Veterinary Medicine, Department of Animals in Science and Society, Utrecht University, The Netherlands.; Institute for Laboratory Animal Science, Hannover Medical School, Germany., Vries RB; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands., Reijmer J; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands., Holthaus D; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands., Visser D; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands., Heming A; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands., Elzinga J; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands., Kempkes RW; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands., Beumer W; ProQR Therapeutics NV, Leiden, The Netherlands., Punt C; ProQR Therapeutics NV,Leiden, the Netherlands; Present position: BunyaVax BV, Lelystad, The Netherlands., Meijboom FL; Faculty of Veterinary Medicine, Department of Animals in Science and Society, Utrecht University, The Netherlands., Ritskes-Hoitinga M; SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, The Netherlands.; Department of Clinical Medicine, Aarhus University, Denmark.
Publikováno v:
Laboratory animals [Lab Anim] 2021 Aug; Vol. 55 (4), pp. 307-316. Date of Electronic Publication: 2021 Feb 08.
Autor:
Leenaars CH; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.; Faculty of Veterinary Medicine, Department of Animals in Science and Society, Utrecht University, Utrecht, The Netherlands.; Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany., De Vries RB; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Heming A; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Visser D; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Holthaus D; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Reijmer J; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Elzinga J; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Kempkes RW; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands., Punt C; ProQR Therapeutics NV, Leiden, The Netherlands., Beumer W; ProQR Therapeutics NV, Leiden, The Netherlands., Meijboom FL; Faculty of Veterinary Medicine, Department of Animals in Science and Society, Utrecht University, Utrecht, The Netherlands., Ritskes-Hoitinga M; SYRCLE, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Laboratory animals [Lab Anim] 2020 Aug; Vol. 54 (4), pp. 330-340. Date of Electronic Publication: 2019 Aug 14.
Autor:
Ritskes-Hoitinga M; SYRCLE, Department for Health Evidence (section HTA), Radboud Institute for Health Sciences, Radboud University Medical Centre, 6500 HB Nijmegen, The Netherlands., Leenaars C; Unit Animals in Science and Society, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3508 TD Utrecht, The Netherlands.; Institute for Laboratory Animal Science, Hannover Medical School, 30625 Hannover, Germany., Beumer W; ProQR Therapeutics NV, 2333 CK Leiden, The Netherlands., Coenen-de Roo T; Central Animal Facility, Leiden University Medical Centre, 2300 RC Leiden, The Netherlands., Stafleu F; Ethics Institute, Faculty of Humanities, Utrecht University, 3508 TC Utrecht, The Netherlands., Meijboom FLB; Unit Animals in Science and Society, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3508 TD Utrecht, The Netherlands.; Ethics Institute, Faculty of Humanities, Utrecht University, 3508 TC Utrecht, The Netherlands.
Publikováno v:
Animals : an open access journal from MDPI [Animals (Basel)] 2020 Jul 10; Vol. 10 (7). Date of Electronic Publication: 2020 Jul 10.
Autor:
Lee YJ; Department of Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea., Jo DH; Department of Anatomy and Cell Biology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea. lawrenc2@snu.ac.kr.
Publikováno v:
Stem cell reviews and reports [Stem Cell Rev Rep] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.